上海医药产业集群研究报告(5)
参见附件。
Enacting laws on Intellectual Property Rights, especially focusing on the issue of sharing know-how between local and foreign companies.
Encourage fair competition by setting and perfecting industry regulations.
Avoid extra intervention by leaving the control to market incentives, industry associations and institutions of collaboration.
Using policy incentives to strengthen the connection among related industries as well as the flow of information.
Direct the cluster to innovation and technology-based cluster.
For company strategies
Fully leverage the home base advantage, ally with related companies by setting up collaborated research centers and information databases.
Import new technology and learn the know-how rather than rely on the cheap cost.
Diversify the portfolio of investment by attracting capital from private sector rather than only from government lending.
Focusing on developing a unique value chain, which includes cooperative relationship with hospitals and medical schools, transportation companies, and so on.
Setting up Chinese medicine research centers, and put efforts into the combination of Chinese and western medicines, to meet the growing need for Chinese medicine and expand the market.
References：
1.Resource from http://www.pharma-engine.com/EN/index.asp, homepage of Shanghai Zhangjiang Pharmaceutical Public Information Service Platform.
2.Resource from the homepage of ZHANGJIANG HIGH-TECH PARK, http://www.zjpark.com/Second.aspx?infoitem_id=65&infoitem_pid=5
3. Resource from the homepage of ZHANGJIANG HIGH-TECH PARK, general introduction of the cluster, http://www.zjpark.com/Second.aspx?infoitem_id=384&infoitem_pid=213&CPI=1
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
Enacting laws on Intellectual Property Rights, especially focusing on the issue of sharing know-how between local and foreign companies.
Encourage fair competition by setting and perfecting industry regulations.
Avoid extra intervention by leaving the control to market incentives, industry associations and institutions of collaboration.
Using policy incentives to strengthen the connection among related industries as well as the flow of information.
Direct the cluster to innovation and technology-based cluster.
For company strategies
Fully leverage the home base advantage, ally with related companies by setting up collaborated research centers and information databases.
Import new technology and learn the know-how rather than rely on the cheap cost.
Diversify the portfolio of investment by attracting capital from private sector rather than only from government lending.
Focusing on developing a unique value chain, which includes cooperative relationship with hospitals and medical schools, transportation companies, and so on.
Setting up Chinese medicine research centers, and put efforts into the combination of Chinese and western medicines, to meet the growing need for Chinese medicine and expand the market.
References：
1.Resource from http://www.pharma-engine.com/EN/index.asp, homepage of Shanghai Zhangjiang Pharmaceutical Public Information Service Platform.
2.Resource from the homepage of ZHANGJIANG HIGH-TECH PARK, http://www.zjpark.com/Second.aspx?infoitem_id=65&infoitem_pid=5
3. Resource from the homepage of ZHANGJIANG HIGH-TECH PARK, general introduction of the cluster, http://www.zjpark.com/Second.aspx?infoitem_id=384&infoitem_pid=213&CPI=1
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件。